Failure of dabigatran following idarucizumab and omeprazole administration

被引：1
|
作者：
Mahawish, Karim M. [1 ]
Leung, Almond [1 ]
机构：
[1] MidCent DHB, Dept Internal Med, Palmerston North, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 01期
关键词：
THROMBIN TIME;
D O I：
10.1111/imj.15159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [31] Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
    Radoslaw Litwinowicz
    Janusz Konstanty-Kalandyk
    Tadeusz Goralczyk
    Krzysztof Bartus
    Piotr Mazur
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 9 - 12
  • [32] Redistribution of dabigatran after idarucizumab administration in a 90-year-old woman with renal failure due to persistent large intestinal bleeding
    Lopatowska, Paulina
    Mlodawska, Elzbieta
    Sobkowicz, Bozena
    van Ryn, Joanne
    Tomaszuk-Kazberuk, Anna
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (12): : 932 - 933
  • [33] Idarucizumab (Praxbind) Antidote against dabigatran (Pradaxa)
    不详
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (21)
  • [34] Idarucizumab as Dabigatran-Antidote is effective and safe
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (19) : 1413 - 1413
  • [35] Refractory Dabigatran-Induced Hemorrhage Despite Multiple Idarucizumab Administration and Renal Replacement Therapy
    Flynn, Francis
    Richard, Guillaume
    Dobrescu, Marc A.
    Bouchard, Josee
    Williamson, David
    Brindamour, Dave
    Charbonney, Emmanuel
    Dupuis, Sebastien
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (02) : 302 - 307
  • [36] Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation
    Yogaratnam, Dinesh
    Ditch, Kristen
    Medeiros, Kristin
    Doyno, Cassandra
    Fong, Jeffrey J.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (10) : 847 - 854
  • [37] Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    van Ryn, Joanne
    Eikelboom, John W.
    Glund, Stephan
    Bernstein, Richard A.
    Dubiel, Robert
    Huisman, Menno V.
    Hylek, Elaine M.
    Kam, Chak-Wah
    Kamphuisen, Pieter W.
    Kreuzer, Joerg
    Levy, Jerrold H.
    Royle, Gordon
    Sellke, Frank W.
    Stangier, Joachim
    Steiner, Thorsten
    Verhamme, Peter
    Wang, Bushi
    Young, Laura
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05): : 431 - 441
  • [38] Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment
    Eikelboom, John W.
    van Ryn, Joanne
    Reilly, Paul
    Hylek, Elaine M.
    Elsaesser, Amelie
    Glund, Stephan
    Pollack, Charles V.
    Weitz, Jeffrey I.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (14) : 1760 - 1768
  • [39] Dabigatran reversal with idarucizumab prior to lung transplantation
    Harano, Takashi
    Rivosecchi, Ryan M.
    Morrell, Matthew R.
    Sanchez, Pablo G.
    CLINICAL TRANSPLANTATION, 2021, 35 (01)
  • [40] Alteplase/dabigatran-etexilate/idarucizumabLack of efficacy following concomitant administration of idarucizumab and alteplase and second stroke due to hyper-coagulative effect of dabigatran-etexilate: case report
    Reactions Weekly, 2019, 1765 (1) : 24 - 24
12345